Marineo Giuseppe
Delta Research and Development, Research Center for Medical Bioengineering, Tor Vergata University, Rome, Italy.
JOP. 2003 Jan;4(1):1-10.
Visceral pain characterizing pancreatic cancer is the most difficult symptom of the disease to control and can significantly impair the quality of life which remains and increase the demand for euthanasia.
To investigate a possible new method based on biophysical principles (scrambler therapy) to be used in the effective treatment of drug-resistant oncological pain of the visceral/neuropathic type.
Eleven terminal cancer patients (3 pancreas, 4 colon, 4 gastric) suffering from elevated drug resistant visceral pain.
The trial program was related to the first ten treatment sessions. Subsequently, each patient continued to receive treatment until death.
Pain measures were performed using the visual analogue scale before and after each treatment session and accompanied by diary recordings of the duration of analgesia in the hours following each single application. Any variation in pain-killing drug consumption was also recorded.
All patients reacted positively to the treatment throughout the whole reference period. Pain intensity showed a significant decrease (P<0.001), accompanied by a gradual rise both in the pain threshold and the duration of analgesia. Nine (81.8%) of the patients suspended pain-killers within the first 5 applications, while the remaining two (18.2%) considerably reduced the dosage taken prior to scrambler therapy. No undesirable side effects were observed. Compliance was found to be optimal.
The preliminary results obtained using scrambler therapy are extremely encouraging, both in terms of enhanced pain control after each treatment session and in view of the possible maintenance of effectiveness over time.
胰腺癌的内脏痛是该疾病最难控制的症状,会严重损害患者剩余的生活质量,并增加安乐死的需求。
研究一种基于生物物理原理的新方法(扰频器疗法),用于有效治疗内脏/神经性耐药肿瘤疼痛。
11名晚期癌症患者(3例胰腺癌、4例结肠癌、4例胃癌),均患有耐药性升高的内脏痛。
试验方案涉及前十个治疗疗程。随后,每位患者持续接受治疗直至死亡。
每次治疗前后使用视觉模拟量表进行疼痛测量,并记录每次单次治疗后数小时内镇痛持续时间的日记。还记录了止痛药物消耗的任何变化。
在整个参考期内,所有患者对治疗均有积极反应。疼痛强度显著降低(P<0.001),同时疼痛阈值和镇痛持续时间逐渐升高。9名(81.8%)患者在前5次治疗中停用了止痛药,其余两名(18.2%)患者大幅减少了扰频器治疗前的用药剂量。未观察到不良副作用。发现依从性最佳。
使用扰频器疗法获得的初步结果非常令人鼓舞,无论是每次治疗后疼痛控制的增强,还是随着时间推移有效性的可能维持。